👀 Ones to watch: The MOST undervalued shares to buy right nowSee Undervalued Shares

Saba Capital Management acquires $49,540 in Gabelli healthcare stock

Published 26/11/2024, 00:46
GRX
-

Saba Capital Management, L.P., a significant shareholder in Gabelli Healthcare & WellnessRx Trust (NYSE:GRX), has recently increased its stake in the company. According to a recent SEC filing, the firm purchased 4,876 shares of common stock on November 22 at a price of $10.16 per share. This acquisition represents a total investment of $49,540.

Following this transaction, Saba Capital Management now holds a total of 1,871,028 shares in the healthcare-focused investment trust. The transaction was executed under the management of Boaz Weinstein, a well-known figure in the financial sector, who is also a ten percent owner of the trust.

This latest move by Saba Capital Management reflects its ongoing interest in Gabelli Healthcare & WellnessRx Trust, a firm known for its investments in the healthcare and wellness industries.

InvestingPro Insights

Saba Capital Management's recent investment in Gabelli Healthcare & WellnessRx Trust (NYSE:GRX) aligns with some interesting financial metrics and trends. According to InvestingPro data, GRX currently has a market capitalization of $161.48 million, positioning it as a smaller player in the investment trust space.

One of the most notable aspects of GRX is its dividend yield, which stands at an attractive 5.85% based on recent data. This high yield is supported by an InvestingPro Tip that highlights GRX's consistent dividend payments over the past 13 years, a factor that likely appeals to income-focused investors like Saba Capital Management.

However, potential investors should be aware that GRX faces some challenges. An InvestingPro Tip indicates that the company suffers from weak gross profit margins, which could impact its overall financial health. Additionally, the stock's valuation implies a poor free cash flow yield, suggesting that the company may be facing some financial constraints.

Despite these concerns, GRX has shown strong price performance over the past year, with a 23.84% total return. This performance, combined with the stock's relatively low price volatility (another InvestingPro Tip), may have factored into Saba Capital Management's decision to increase its stake.

For investors seeking a more comprehensive analysis, InvestingPro offers additional tips and insights on GRX. In fact, there are 9 more InvestingPro Tips available for this stock, providing a deeper understanding of its financial position and market dynamics.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.